ArticleBMC cancer2025

Targeting EP300 in diffuse large b-cell lymphoma: efficacy of A485 and synergistic effects with XPO1 inhibition.

Yanan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.